Supply of Hemostatic Agents II

Summary

The tender concerns the recurring supply of hemostatic agents to meet the hospital’s needs over a two-year period. It is divided into five lots; the detailed lot structure is set out in the tender documents. Each lot will be evaluated separately, and the sole award criterion is the total bid price excluding VAT for the two-year period. The estimated total value is CZK 4,738,630. Bids must be submitted electronically by 31 October 2026 at 10:00. No bid guarantee is required. In performing the contract, the supplier must take environmental protection, decent working conditions and occupational safety for employees, and fair supply-chain relationships into account.